FDA Approved: SOMAVERT — Supplemental Application (Pharmacia & Upjohn Company LLC)

View source ↗

Summary

The FDA approves a supplemental application for Somavert (pegvisomant) submitted by Pharmacia & Upjohn Company LLC. Somavert is used for treating acromegaly.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acromegaly

Drugs mentioned

• Somavert (pegvisomant)

Snippet

SUPPL AP for SOMAVERT (PEGVISOMANT)